John P. Butler Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John P. Butler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John P. Butler. John P. Butler is Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in Relypsa Inc ($RLYP) and CEO & President in Akebia Therapeutics, Inc. ($AKBA) and CEO and President in Akebia Therapeutics, Inc. ($AKBA) and Director in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Latest Insider Trading Transactions of John P. Butler
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, KERX, RLYP, ZYNE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Sell | S | 3.40 | 4,109 | 13,971 | 1,152,153 | 1.2 M to 1.2 M (-0.36 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 39,520 | 0 | 1,156,262 | 1.1 M to 1.2 M (+3.54 %) |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 8.87 | 403,600 | 3,579,932 | 403,600 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 237,400 | 0 | 1,026,632 | 789.2 K to 1 M (+30.08 %) |
| Nov 21 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | P | 3.44 | 50,000 | 172,000 | 887,732 | 837.7 K to 887.7 K (+5.97 %) |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
| Jun 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 287,000 | 134,890 | 0 | |
| Jun 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 287,000 | 134,890 | 836,232 | 549.2 K to 836.2 K (+52.25 %) |
| Mar 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 7.28 | 350,000 | 2,548,000 | 350,000 | |
| Mar 05 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 239,500 | 0 | 614,382 | 374.9 K to 614.4 K (+63.89 %) |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO & President | Payment of Exercise | F | 8.94 | 135,697 | 1,213,131 | 374,617 | 510.3 K to 374.6 K (-26.59 %) |
| Aug 22 2018 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Buy | P | 6.43 | 5,000 | 32,153 | 5,000 | 0 to 5 K |
| Jul 12 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 100,000 | 47,000 | 287,000 | |
| Jul 12 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 100,000 | 47,000 | 510,314 | 410.3 K to 510.3 K (+24.37 %) |
| Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
| Apr 16 2018 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 9.90 | 35,000 | 346,500 | 35,000 | |
| Mar 02 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 14.30 | 126,300 | 1,806,090 | 126,300 | |
| Mar 02 2018 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 88,900 | 0 | 408,814 | 319.9 K to 408.8 K (+27.79 %) |
| Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Butler John P. | Director | Option Exercise | A | 6.56 | 30,000 | 196,800 | 30,000 | |
| Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | Butler John P. | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Feb 23 2017 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 0.00 | 190,000 | 0 | 190,000 | |
| Feb 23 2017 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 119,500 | 0 | 317,780 | 198.3 K to 317.8 K (+60.27 %) |
| Jan 23 2017 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 20,000 | 9,400 | 387,000 | |
| Jan 23 2017 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 20,000 | 9,400 | 373,480 | 353.5 K to 373.5 K (+5.66 %) |
| Sep 02 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | D | 17.00 | 4,500 | 76,500 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | D | 35.79 | 4,500 | 161,055 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | D | 23.96 | 3,828 | 91,719 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | D | 11.00 | 24,632 | 270,952 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Sell | D | 32.00 | 2,250 | 72,000 | 0 | 2.3 K to 0 (-100.00 %) |
| Sep 02 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Sell | U | 32.00 | 2,849 | 91,168 | 2,250 | 5.1 K to 2.3 K (-55.87 %) |
| Jun 23 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | A | 17.00 | 4,500 | 76,500 | 4,500 | |
| Jun 23 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Grant | A | 0.00 | 2,250 | 0 | 5,099 | 2.8 K to 5.1 K (+78.98 %) |
| Jun 08 2016 | RLYP | Relypsa Inc | Butler John P. | Director | Sell | S | 19.32 | 1,013 | 19,570 | 2,849 | 3.9 K to 2.8 K (-26.23 %) |
| May 27 2016 | KERX | KERYX BIOPHARMACEU ... | Butler John P. | Director | Option Exercise | A | 5.71 | 30,000 | 171,300 | 30,000 | |
| May 27 2016 | KERX | KERYX BIOPHARMACEU ... | Butler John P. | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Feb 24 2016 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 7.70 | 190,550 | 1,467,235 | 190,550 | |
| Feb 24 2016 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 125,500 | 0 | 351,173 | 225.7 K to 351.2 K (+55.61 %) |
| Jan 19 2016 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 25,000 | 11,750 | 407,000 | |
| Jan 19 2016 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 25,000 | 11,750 | 225,673 | 200.7 K to 225.7 K (+12.46 %) |
| Jun 15 2015 | RLYP | Relypsa Inc | Butler John P. | Director | Sell | S | 34.62 | 1,100 | 38,087 | 3,862 | 5 K to 3.9 K (-22.17 %) |
| Jun 08 2015 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
| Jun 08 2015 | RLYP | Relypsa Inc | Butler John P. | Director | Grant | A | 0.00 | 2,250 | 0 | 4,962 | 2.7 K to 5 K (+82.96 %) |
| May 28 2015 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 50,000 | 23,500 | 0 | |
| May 28 2015 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 50,000 | 23,500 | 198,350 | 148.4 K to 198.4 K (+33.70 %) |
| Mar 11 2015 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | M | 0.47 | 100,000 | 47,000 | 0 | |
| Mar 11 2015 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | M | 0.47 | 100,000 | 47,000 | 148,350 | 48.4 K to 148.4 K (+206.83 %) |
| Mar 10 2015 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 11.15 | 150,000 | 1,672,500 | 150,000 | |
| Jun 23 2014 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | A | 23.96 | 3,828 | 91,719 | 3,828 | |
| Jun 23 2014 | RLYP | Relypsa Inc | Butler John P. | Director | Grant | A | 0.00 | 2,712 | 0 | 2,712 | 0 to 2.7 K |
| Nov 18 2013 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | A | 11.00 | 8,247 | 90,717 | 8,247 | |
| Nov 18 2013 | RLYP | Relypsa Inc | Butler John P. | Director | Option Exercise | A | 11.00 | 16,385 | 180,235 | 16,385 |
Page: 1